CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $552K invested in Chemomab Therapeutics in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $606K → $552K (-$54.2K)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24.9K | |
| 2 | +$23K | |
| 3 | +$17.1K | |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
+$8.65K |
| 5 |
Morgan Stanley
New York
|
+$1.37K |
Top Sellers
| 1 | -$67.7K | |
| 2 | -$25.7K | |
| 3 | -$18K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.84K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$656 |